This Ninja pressure cooker lid could burn you, Health Canada warns in recall
Health Canada says a burn risk has led the agency to recall a pressure cooker lid that has resulted in more than 100 injuries in the United States.
The recall notice posted Thursday says the pressure cooker lid on several models of Ninja Foodi Tendercrisp multi-cookers can be opened during cooking, 'causing hot contents to escape' and 'posing a potential risk of burn injuries to consumers.'
'Immediately stop using the multi-cookers' pressure-cooking function, discard the pressure-cooking lid, and contact SharkNinja to arrange for a replacement pressure-cooking lid,' Health Canada said, using the name of the company behind the product.
Get weekly health news
Receive the latest medical news and health information delivered to you every Sunday. Sign up for weekly health newsletter Sign Up
By providing your email address, you have read and agree to Global News' Terms and Conditions and Privacy Policy
Other functions like air frying remain safe to use, the notice says.
The recall notice includes a list of seven affected models of the multi-cooker and information on how to contact SharkNinja to receive a new lid.
Story continues below advertisement
The affected products were sold between January 2019 and April 2025.
Health Canada said the company has received five reports of the lids being opened during use in Canada out of more than 184,000 products sold. No injuries have been reported.
In the U.S., 106 reports of injury have been received by the company out of more than 1.8 million products sold.
The U.S. Consumer Product Safety Commission's recall notice for the lids says more than 50 of the reported injuries involve second or third-degree burns to the face or body. It says 26 lawsuits have been filed to date.
The U.S. notice says the products were sold at Walmart, Costco, Sam's Club, Amazon and Target stores nationwide and online, as well as on Ninja's online store.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Vancouver Sun
5 hours ago
- Vancouver Sun
Opinion: Living with multiple sclerosis is difficult. Living in B.C. makes it harder
I was diagnosed with multiple sclerosis in September 2024. MS is a chronic, progressive disease of the central nervous system that can affect your vision, balance, cognition, and mobility. My diagnosis was a gut-punch — after years of hard work building my filmmaking career, my future was suddenly in jeopardy. The diagnosis took a predictably emotional toll on my family and me. Plans we had made for the future were now question marks. Through the support of my family and friends, plus lots of therapy, I've accepted my diagnosis for what it is — a totally unexpected development in my life. MS is unpredictable and deeply personal — no two people experience it the same way. But while MS is unpredictable, access to treatment shouldn't be. Yet in B.C., it is. A daily roundup of Opinion pieces from the Sun and beyond. By signing up you consent to receive the above newsletter from Postmedia Network Inc. A welcome email is on its way. If you don't see it, please check your junk folder. The next issue of Informed Opinion will soon be in your inbox. Please try again Interested in more newsletters? Browse here. B.C. is the only province in Canada that does not provide public coverage for Health Canada-approved, anti-CD20 therapies for relapsing MS — ofatumumab and ocrelizumab. These treatments reduce relapses, delay progression, and improve long-term health outcomes. Unless you have special private insurance or happen to be employed by the provincial government (which covers these drugs under its internal employee drug plan), the out-of-pocket costs of these drugs are prohibitive for people such as me. When I was diagnosed with MS, my neurologist explained that ofatumumab was the most appropriate therapy for me — not only because of its strong results, but because some of the other treatments could worsen my Type-1 diabetes and related complications such as diabetic retinopathy. But because PharmaCare does not cover ofatumumab, I'm instead being offered alternative drugs that are less effective, and that will worsen my diabetes control. Thankfully, I was able to access ofatumumab through a six-month bridge program offered by the manufacturer, and I began treatment this past January. I'm happy to report that I've tolerated the drug extremely well. It's exactly what I need to manage my MS and keep living a normal, productive and full life. But the bridge program ends in a matter of days. I'm facing the very real possibility of having to switch to a higher-risk alternative simply because of where I live in Canada. My family and I are now having conversations about leaving the province. This is an equity issue, plain and simple. For people such as me, this doesn't just affect our health — it impacts our ability to plan ahead and to build stable lives. MS often strikes during our most productive years, and it can force people out of the workforce far earlier than they should be. However, early, effective treatment helps people stay healthier, more independent, and more engaged in their communities. At the very least, those of us who can't take the publicly funded options due to other health conditions should not be left behind. The alternative shouldn't be settling for a drug that is clinically inappropriate for me, simply because it's cheaper for the system. That's not good medicine, and it's certainly not good policy. I'm not asking for special treatment. I'm asking for fair treatment. For myself and for every British Columbian living with MS. I'm asking for the ability to manage my disease based on what works for me, not on what PharmaCare happens to cover. I'm lucky to have mild symptoms and a supportive medical team, but even still, the gruelling process of trying to access the right treatment has been emotionally exhausting, adding a layer of grief during an already difficult time. I urge the B.C. government to fund all Health Canada-approved MS treatments through PharmaCare and ensure that people across this province can access the medications they need, when they need them. Teresa Alfeld is a film director based in Vancouver. She was diagnosed with relapsing MS in 2024 and diagnosed with Type 1 diabetes in 1994.
Global News
10 hours ago
- Global News
Doctors, health experts call on N.S. to cover birth control and HIV-prevention drug
Nova Scotia physicians and other sexual health experts are calling on the provincial government to fund birth control and increase access to a medication used to prevent HIV. Four doctors, the head of the Halifax Sexual Health Centre, and a pharmacy professor made the comments today at a legislature committee hearing in Halifax. Abbey Ferguson with the Halifax Sexual Health Centre says PrEP — an antiviral medication that prevents HIV transmission — is so expensive that many people who would benefit from the drug are not able to take it. Get weekly health news Receive the latest medical news and health information delivered to you every Sunday. Sign up for weekly health newsletter Sign Up By providing your email address, you have read and agree to Global News' Terms and Conditions and Privacy Policy The drug is estimated to cost between $200 and $250 per month. Dr. Melissa Brooks, the medical co-director of the Reproductive Options and Services Clinic, says the province's pharmacare plan is so restrictive that it often doesn't help those who cannot afford their preferred birth control option. Story continues below advertisement Kari Ellen Graham, with Access Now Nova Scotia, urged the provincial government to sign on to the federal government's pharmacare program, which helps fund birth control. So far only P.E.I., Manitoba, British Columbia, and the Yukon have signed up to the federal pharmacare program. This report by The Canadian Press was first published June 10, 2025.
Global News
11 hours ago
- Global News
N.S. woman wrongly diagnosed with terminal cancer: ‘Absolutely devastating'
A week ago, 31-year-old Gabriella Patey was told she had advanced-stage breast cancer and was expected to have only months to live. Armed with the 'grim diagnosis' that had also claimed her mother's life, Patey began telling family and friends and making end-of-life preparations. 'I put a claim in through my bank for critical illness insurance and just put my name on the list for medically assisted dying,' the Halifax-area woman said. 'I just came to terms with it. This is what it was, just absolutely devastating.' But days later, Patey's family physician called with shocking news. 'I got another call from my primary care physician stating, actually, there had been a critical patient error at the IWK (Health Centre). And the file with the grim diagnosis did not even belong to me,' she said. Story continues below advertisement 'I didn't even really believe her. I mean why should I? They had made this mistake once, how could they make it again?' Initially told tumour was benign Patey first discovered a lump in her breast in October 2023, just a few weeks after her mother died of breast cancer. She went to the Breast Health Clinic at the IWK Health Centre in Halifax over the course of a year and had multiple ultrasounds. 'Throughout that entire process I said, 'You know, is doing a mastectomy an option because of my history?' They stated, quote-unquote, 'We're not there yet.'' She had a biopsy on the tissue from her left breast at the end of April this year. On May 17, Patey said she received a call with 'great news, 'and was told the tumour was benign and had no traces of breast cancer. Get weekly health news Receive the latest medical news and health information delivered to you every Sunday. Sign up for weekly health newsletter Sign Up By providing your email address, you have read and agree to Global News' Terms and Conditions and Privacy Policy 'My husband and I obviously celebrated. We told all my friends and family, it was just such a big relief.' Two and a half weeks later on June 4, her family doctor called to tell her there had been a mistake and she did indeed have cancer. The devastating news came just five days after she finished a successful thyroid cancer treatment. Story continues below advertisement Patey provided Global News with a copy of the written biopsy result stating 'breast tissue (left upper outer quadrant mass)' was found to have 'invasive ductal carcinoma.' She credits her family physician, who also works in the IWK part-time, for pursuing the truth about her diagnosis. By Friday — two days after her terminal diagnosis — her family physician confirmed it was actually an error. Patey's lab report states 'breast tissue (left breast mass at 10 to 12 o'clock)' had 'benign breast tissue' and was 'negative for in situ and invasive malignancy.' Furthermore, her family doctor physically went to the IWK to check the slides. 'A director in the pathology department spoke to my primary care physician directly … and verbally admitted that it was a critical patient error,' she said. 'They are investigating it but she can't comment anymore because it is an ongoing investigation. So no, I have no idea if the other woman has found out and they haven't admitted anything to me on paper.' At this point, Patey isn't confident about her biopsy results and wants to receive something in writing. 'The first thing I'm looking for is an apology' Patey said she is left doubting Nova Scotia's health-care system and is pursuing legal action. Story continues below advertisement But the first thing she wanted was an explanation and an apology. 'I have called them 17 times. I've left multiple messages. I've filed a complaint with the Nova Scotia Health Authority. I filed a complaint through the patient advocate services to the IWK, and I have received absolutely no response, not an apology, nothing, absolutely nothing,' she said Monday. 'I wouldn't even have known about this error, I don't think, at this point in time, if it wasn't for my primary care physician looking at me like I'm an actual human being, and I'm not just a number in a system somewhere.' Patey received a call Tuesday from an IWK representative who confirmed the error and apologized. They said a written explanation was coming. Through it all, Patey said she and her family have been left traumatized by what happened. 'It's absolutely devastating to get a diagnosis like that. I had to look my husband in the face and tell him,' she said. '(We have) all these plans for our future and (I had to) say, 'I may not be here to live out those plans with you.' I mean we're crying ourselves to sleep every night.' And the fact there is another woman and family out there impacted by this error weighs heavily on her. Story continues below advertisement 'The part that also breaks my heart is there is a poor woman out there walking around thinking that she has a benign breast tumour and she has cancer. She has a terminal illness and she might not have any idea,' she said. 'If this happened to me, who else does it happen to and who else will it happen to? There has to be something in place so this doesn't happen again to anybody.' In a statement to Global News, a spokesperson from IWK Health said 'concerns of this nature are taken seriously.' 'Due to patient privacy, IWK Health is unable to comment on specific cases,' wrote spokesperson Andrea Slaney. 'However, concerns of this nature are taken seriously and a formal investigation process is followed with engagement from IWK's Quality, Patient Safety and Patient Experience team.'
